MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2026 International Congress

    Social Cognition in Patients with Parkinson’s Disease

    A. Kim, M. Kim (Cheongju, Republic of Korea)

    Objective: We aimed to investigate social cognition in patients with Parkinson's disease (PD) using facial affect tasks of the Florida Affect Battery (FAB). Background: Patients with…
  • 2026 International Congress

    Plasma p-tau217 outperforms p-tau181 as a biomarker of Alzheimer’s disease co-pathology in the Lewy Body Disorders spectrum

    E. Fiorenzato, S. Cauzzo, G. Musso, R. Biundo, C. Ceolin, C. Fogliano, C. Cosma, W. Meissner, V. Misenti, S. Moz, ML. Nasi, F. Vianello, R. Manara, M. Montagnana, G. Sergi, A. Antonini (Padova, Italy)

    Objective: To evaluate the relative performance of plasma p-tau217 and p-tau181 as biomarkers of Alzheimer’s disease (AD)  co-pathology across the Lewy body disorders (LBD)  spectrum.…
  • 2026 International Congress

    Lifestyle Factors as Predictors of Progression in Parkinson’s Disease

    X. Zhang, X. Chen, C. Christine, A. Hung, M. Schwarzschild, A. Ascherio, M. Flores Torres, K. Bjornevik (Boston, USA)

    Objective: To prospectively examine the associations of physical activity, smoking, caffeine intake, multivitamin use, and adherence to the MIND diet with disease progression among people…
  • 2026 International Congress

    Multiplexed Serum Biomarkers for Differentiating the Parkinson’s Disease Continuum and Disease Severity

    MS. Kim, IH. Kwak, JK. Yu, H. Ma, K. Choi, J. Kim, H. Hwang, YE. Kim (Hwaseong, Republic of Korea)

    Objective: Reliable blood biomarkers for identifying the Parkinson’s disease (PD) spectrum and reflecting disease severity remain limited. We investigated whether multiple serum biomarkers could differentiate…
  • 2026 International Congress

    fMRI Activity during Working Memory Manipulation is Associated with Caudate Integrity in Early Parkinson’s Disease

    K. Giehl, H. Theis, A. Asendorf, M. Banwinkler, V. Dzialas, R. Lubomierski, M. Hönig, T. van Eimeren (Juelich, Germany)

    Objective: This study aimed to determine whether reduced dopaminergic integrity and increased iron deposition in the caudate are associated with altered BOLD activation during high…
  • 2026 International Congress

    Emergence of Cortical Amyloid from the Prodromal Stage of the Lewy Body Disease Spectrum: Evidence from a PiB-PET Study

    M. Yoshita, S. Tsuji, K. Yokoyama (Nanto, Japan)

    Objective: To characterize β-amyloid (Aβ) deposition across the Lewy body disease (LBD) spectrum using Pittsburgh compound B positron emission tomography (PiB-PET) and examine the influence…
  • 2026 International Congress

    Physical Activity is Associated with Attenuated Motor and Cognitive Progression in Parkinson’s Disease

    DW. Ryu, KR. Duque, J. Abanto, L. Marsili, NC. Paredes, AH. Gorriti, H. Deraz, E. Hill, A. Duker, AJ. Espay (Seoul, Republic of Korea)

    Objective: To determine whether physical activity (PA) modifies the rate of motor and cognitive progression in Parkinson’s disease (PD) and to identify specific components of…
  • 2026 International Congress

    Differentiation of Parkinsonian Syndromes Using Cognitive Strategies and Associations with Non-tremor Motor Progression

    A. D'Souza, M. Gibbs, H. Emmett, E. Lwin, C. Sotirakis, C. Antoniades (Oxford, United Kingdom)

    Objective: This study aims to investigate whether cognitive strategies on verbal fluency tasks differentiate Parkinson’s disease (PD) from Progressive Supranuclear Palsy (PSP) and healthy adults, and are associated with the progression of clinical motor symptoms in Parkinson’s…
  • 2026 International Congress

    Data-driven Trajectories of Atrophy Explain Clinical Heterogeneity Across Lewy Body Diseases

    A. Konuri, G. Leal, T. Transcend Consortium, G. Halliday, S. Lewis, R. Weil, R. Landin-Romero, C. Lambert, N. Oxtoby, E. Matar (Sydney, Australia)

    Objective: To identify data-driven spatiotemporal trajectories of brain atrophy across the Lewy body disease spectrum and establish their relationship to clinical heterogeneity, core symptom profiles,…
  • 2026 International Congress

    Distinct Cognitive Profiles in Parkinson’s and Alzheimer’s Disease: Evidence from a Large Neurodegenerative Cohort

    I. Zhukova, M. Matveeva, N. Zhukova, A. Agasheva, D. Novotnyi, S. Shteimetz, Z. Sayfitdinkhuzhaev (Moscow, Russian Federation)

    Objective: To compare cognitive profiles across patients with Parkinson’s disease and Alzheimer’s disease using standardized neuropsychological assessment. Background: Cognitive impairment is a major feature of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley